Results 101 to 110 of about 1,291 (167)

Mitochondrial Dysfunction Driven by MARylation of GLUD1 as a Key Barrier to Sorafenib‐Induced Ferroptosis in Hepatocellular Carcinoma

open access: yesAdvanced Science, EarlyView.
Sorafenib limits its ferroptotic efficacy in hepatocellular carcinoma by triggering a self‐limiting metabolic bottleneck. It drives SIRT4‐mediated mono‐ADP‐ribosylation of GLUD1 at R60, initiating mitophagy‐coupled, non‐canonical ubiquitination via the DTX3L DTC domain.
Kangnan Zhang   +9 more
wiley   +1 more source

Multiomics identifies the link between intratumor steatosis and the exhausted tumor immune microenvironment in hepatocellular carcinoma

open access: yesHepatology, EarlyView., 2022
Steatotic HCC can be diagnosed by MRI and forms a pro‐tumor immune microenvironment with high expression of PD‐L1, M2 polarization of macrophages and activation of CAFs, which may be a good target for combined immunotherapy. Abstract Background and Aims Immunotherapy has become the standard‐of‐care treatment for hepatocellular carcinoma (HCC), but its ...
Hiroki Murai   +29 more
wiley   +1 more source

Bacterial DnaK Promotes CHIP‐Mediated GPX4 Degradation: A Bone‐Targeted DNAzyme–Nanozyme Strategy for Repair of Infected Bone Defects

open access: yesAdvanced Science, EarlyView.
Staphylococcus aureus DnaK promotes ubiquitination and degradation of glutathione peroxidase 4 (GPX4) through the C terminus of Hsc70‐interacting protein (CHIP) in bone marrow mesenchymal stem cells, inducing ferroptosis‐associated injury and impairing osteogenesis.
Le Gao   +7 more
wiley   +1 more source

Proteogenomic characterization of cholangiocarcinoma

open access: yesHepatology, EarlyView., 2022
Proteogenomic characterization of cholangiocarcinoma with therapeutic strategies Abstract Background and Aims Cholangiocarcinoma (CCA) is a highly heterogeneous cancer with limited understanding and few effective therapeutic approaches. We aimed at providing a proteogenomic CCA characterization to inform biological processes and treatment ...
Mengjie Deng   +18 more
wiley   +1 more source

Development‐Informed Microsphere Assemblies Enable Spatiotemporally Programmed Bone–Vascular Organoid‐Like Constructs for Large Bone Defect Repair

open access: yesAdvanced Science, EarlyView.
Single‐cell‐guided prioritization of BMP4 and VEGFA is combined with temporally programmed BMSCs and a Matrigel‐free GelMA/PEO/bioactive‐glass assembled‐microsphere matrix to generate bone–vascular organoid‐like constructs. The platform coordinates osteogenic differentiation, endothelial activation, vascular‐like microchannel formation, and ...
Renhao Ni   +14 more
wiley   +1 more source

Adeno‐associated virus serotype 2 capsid variants for improved liver‐directed gene therapy

open access: yesHepatology, EarlyView., 2022
Abstract Background and Aims Current liver‐directed gene therapies look for adeno‐associated virus (AAV) vectors with improved efficacy. With this background, capsid engineering is explored. Whereas shuffled capsid library screenings have resulted in potent liver targeting variants with one first vector in human clinical trials, modifying natural ...
Nadja Meumann   +25 more
wiley   +1 more source

Hypofractionated Radiotherapy Elicits Tumor‐Derived APOC2 to Drive Inflammatory Monocyte Differentiation and Potentiate Anti‐Tumor Immunity in Colorectal Cancer

open access: yesAdvanced Science, EarlyView.
Hypofractionated radiotherapy relieves ATF3‐mediated repression of tumor‐derived APOC2 in preclinical models, linking lipid remodeling to IFN‐I‐responsive Ly6A+ monocytes and CD8+ T‐cell responses. In patients receiving combined neoadjuvant therapy, rising serum APOC2 associates with pathological complete response.
Qian Xu   +16 more
wiley   +1 more source

AIF1+CSF1R+ MSCs, induced by TNF‐α, act to generate an inflammatory microenvironment and promote hepatocarcinogenesis

open access: yesHepatology, EarlyView., 2022
Mesenchymal stem cells subset, educated by TNF‐α, are involved to generate inflammatory microenvironment and promote hepatocarcinogenesis Abstract Background and Aims Increasing evidence suggests that mesenchymal stem cells (MSCs) home to injured local tissues and the tumor microenvironment in the liver.
Chen Zong   +9 more
wiley   +1 more source

Histone Chaperone ASF1B Promotes Progenitor‐Like Cell States in Hepatocellular Carcinoma Through H3.3‐Dependent SOX9 Transcriptional Activation

open access: yesAdvanced Science, EarlyView.
ASF1B is reactivated as an oncofetal histone chaperone in hepatocellular carcinoma and promotes progenitor‐like malignant cell states. Mechanistically, ASF1B cooperates with H3.3/HIRA‐dependent chromatin regulation to activate SOX9 transcription. ASF1B and H3.3 also exhibit dynamic co‐condensation behavior, suggesting an additional biophysical feature ...
Xiaona Fang   +14 more
wiley   +1 more source

A nationwide assessment of hepatocellular adenoma resection: Indications and pathological discordance

open access: yesHepatology Communications, EarlyView., 2022
Abstract Hepatocellular adenomas (HCAs) are benign liver tumors associated with bleeding or malignant transformation. Data on the indication for surgery are scarce. We analyzed indications and outcome of patients operated for HCAs < 50 mm compared to HCAs ≥ 50 mm. Changes in final postoperative diagnosis were assessed.
Martijn P. D. Haring   +70 more
wiley   +1 more source

Home - About - Disclaimer - Privacy